The effects of the COVID-19 pandemic on community respiratory virus activity

EJ Chow, TM Uyeki, HY Chu - Nature Reviews Microbiology, 2023 - nature.com
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused
substantial global morbidity and deaths, leading governments to turn to non-pharmaceutical …

Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019–June 2021)

RM Kariyawasam, DA Julien, DC Jelinski… - … Resistance & Infection …, 2022 - Springer
Abstract Background Pneumonia from SARS-CoV-2 is difficult to distinguish from other viral
and bacterial etiologies. Broad-spectrum antimicrobials are frequently prescribed to patients …

[HTML][HTML] Global antibiotic use during the COVID-19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020–2022

A Nandi, S Pecetta, DE Bloom - EClinicalMedicine, 2023 - thelancet.com
Background Despite bacterial coinfection rates of less than 10%, antibiotics are prescribed
to an estimated 75% of patients with COVID-19, potentially exacerbating antimicrobial …

Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 …

M Klompas, R Branson, K Cawcutt, M Crist… - Infection Control & …, 2022 - cambridge.org
The purpose of this document is to highlight practical recommendations to assist acute care
hospitals to prioritize and implement strategies to prevent ventilator-associated pneumonia …

A humanized mouse model of chronic COVID-19

E Sefik, B Israelow, H Mirza, J Zhao, R Qu, E Kaffe… - Nature …, 2022 - nature.com
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease that can present as
an uncontrolled, hyperactive immune response, causing severe immunological injury …

COVID-19-associated opportunistic infections: a snapshot on the current reports

A Abdoli, S Falahi, A Kenarkoohi - Clinical and experimental medicine, 2022 - Springer
Abstract Treatment of the novel Coronavirus Disease 2019 (COVID-19) remains a
complicated challenge, especially among patients with severe disease. In recent studies …

[HTML][HTML] Increased detection of carbapenemase-producing Enterobacterales bacteria in Latin America and the Caribbean during the COVID-19 pandemic

GR Thomas, A Corso, F Pasterán, J Shal… - Emerging Infectious …, 2022 - ncbi.nlm.nih.gov
Abstract During 2020–2021, countries in Latin America and the Caribbean reported clinical
emergence of carbapenemase-producing Enterobacterales that had not been previously …

COVID-19 bacteremic co-infection is a major risk factor for mortality, ICU admission, and mechanical ventilation

MJ Patton, CJ Orihuela, KS Harrod, MAN Bhuiyan… - Critical Care, 2023 - Springer
Background Recent single-center reports have suggested that community-acquired
bacteremic co-infection in the context of Coronavirus disease 2019 (COVID-19) may be an …

Decline in pneumococcal disease in young children during the coronavirus disease 2019 (COVID-19) pandemic in Israel associated with suppression of seasonal …

D Danino, S Ben-Shimol… - Clinical Infectious …, 2022 - academic.oup.com
Background The incidence of invasive pneumococcal disease (IPD) declined during the
COVID-19 pandemic. Previous studies hypothesized that this was due to reduced …

Secondary bacterial infection and clinical characteristics in patients with COVID-19 admitted to two intensive care units of an academic hospital in Iran during the first …

S Pourajam, E Kalantari, H Talebzadeh… - Frontiers in cellular …, 2022 - frontiersin.org
Data on the prevalence of bacterial co-infections and secondary infection among adults with
COVID-19 admitted to the intensive care unit (ICU) are rare. We aimed to determine the …